1-3 of 3
Raphael Kranz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML

Clinical Trials & Observations
Lars Bullinger, Konstanze Döhner, Raphael Kranz, Christoph Stirner, Stefan Fröhling, Claudia Scholl, Young H. Kim, Richard F. Schlenk, Robert Tibshirani, Hartmut Döhner, Jonathan R. Pollack
Journal: Blood
Blood (2008) 111 (9): 4490–4495.
https://doi.org/10.1182/blood-2007-09-115055
Published: 2008
Journal Articles

Characterization of NPM1 -Mutated/ FLT3 ITD-Negative Acute Myeloid Leukemia with Normal Karyotype by Gene Expression Profiling.

Lars Bullinger, MD, Konstanze Dohner, MD, Raphael Kranz, Frank G. Rucker, MD, Stefan Frohling, MD, Richard F. Schlenk, MD, Jonathan R. Pollack, MD, PhD, Hartmut Dohner, MD
Journal: Blood
Blood (2006) 108 (11): 155.
https://doi.org/10.1182/blood.V108.11.155.155
Published: 2006
Journal Articles

Prognostic Gene-Expression Signatures in Adult Acute Myeloid Leukemia with Normal Karyotype.

Lars Bullinger, MD, Eric Bair, PhD, Raphael Kranz, Konstanze Dohner, MD, Stefan Frohling, MD, Richard F. Schlenk, MD, Robert Tibshirani, PhD, Hartmut Dohner, MD, Jonathan R. Pollack, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 756.
https://doi.org/10.1182/blood.V106.11.756.756
Published: 2005